Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of AD-2071 and AD-2072 in Healthy Male Volunteers
NCT03632668Phase 1Completed
- Sponsor
- Addpharma, Inc.
- Start
- Sep 2018
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of rosuvastatin, ezetimibe, telmisartan and amlodipine in hyperlipidemia and hypertension (HTN), sponsored by Addpharma, Inc. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Sep 2018; status: completed.
02
Drugs
rosuvastatinezetimibetelmisartanamlodipine
03
Conditions
hyperlipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT03632668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632668.